05/30/2012
Today MD Anderson submitted a letter to CPRIT related to CPRIT’s request for application and ultimate granting to MD Anderson of the first incubator infrastructure award. In its letter, MD Anderson shares plans to establish an internal business process for future commercialization award submissions, and also makes two proactive recommendations to CPRIT. First, it offers to resubmit its business plan for any additional...
E3 ligase’s role makes it target for defeating Herceptin resistance, stifling cancer’s preferred diet
MD Anderson News...
May 9 luncheon honors Right Honourable Tony Blair in interview with Greta Van Susteren, raising more than $773,000
MD Anderson...
Three-pronged study reveals high response rate in other advanced melanoma patients and activity in multiple cancers
MD Anderson News Release 05/17/12
An experimental drug targeting a common mutation in melanoma successfully shrank tumors that spread to the brain in nine out of 10 patients in part of an international phase I clinical trial report in the May 18 issue of The Lancet.
The drug dabrafenib,...
Listen to: Cancer vaccine to prevent breast cancer recurrence
Novel adjuvant therapy...
Cell surface protein blows potent cells’ cover; targeted drug works in preclinical tests
MD Anderson News Release 05/16...
Papadopoulos Launches Multidisciplinary Prostate Clinic
MD Anderson News Release 05/15/2012
John Papadopoulos,...
Papadopoulos Launches Multidisciplinary Prostate Clinic
MD Anderson News Release 05/15/2012
John Papadopoulos,...
MD Anderson News Release 05/11/12
The University of Texas MD Anderson Cancer Center will renew a collaborative agreement with the Norwegian...
MD Anderson News Release 05/11/12
The University of Texas MD Anderson Cancer Center and the Norwegian Cancer Consortium (NCC) will host...